Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LLY
|
Stephen F Fry
SVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct | 7,609 Reduced 7.06% |
$619,753
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Stephen F Fry
SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct | 17,060 Added 13.66% |
-
|
Feb 01
2018 |
|
LLY
|
Michael J Harrington
Senior VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 10,811 Reduced 10.52% |
$880,556
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Michael J Harrington
Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 24,524 Added 19.27% |
-
|
Feb 01
2018 |
|
LLY
|
Jan M Lundberg
EVP,Science&Tech and Pres. LRL |
SELL
Payment of exercise price or tax liability
|
Direct | 16,169 Reduced 7.55% |
$1,316,965
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Jan M Lundberg
EVP,Science&Tech and Pres. LRL |
BUY
Exercise of conversion of derivative security
|
Direct | 36,252 Added 14.47% |
-
|
Feb 01
2018 |
|
LLY
|
Susan Mahony
SVP & Pres., Lilly Oncology |
SELL
Payment of exercise price or tax liability
|
Direct | 9,533 Reduced 15.8% |
$776,463
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Susan Mahony
SVP & Pres., Lilly Oncology |
BUY
Exercise of conversion of derivative security
|
Direct | 21,326 Added 26.11% |
-
|
Feb 01
2018 |
|
LLY
|
David A Ricks
President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,559 Reduced 6.79% |
$778,581
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
David A Ricks
President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 21,326 Added 13.15% |
-
|
Feb 01
2018 |
|
LLY
|
David A Ricks
President, Chair, and CEO |
SELL
Bona fide gift
|
Direct | 11,764 Reduced 8.96% |
-
|
Feb 01
2018 |
|
LLY
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
SELL
Payment of exercise price or tax liability
|
Direct | 7,133 Reduced 10.91% |
$580,983
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
BUY
Exercise of conversion of derivative security
|
Direct | 15,993 Added 19.66% |
-
|
Feb 01
2018 |
|
LLY
|
Jeffrey N Simmons
SVP&Pres. Elanco Animal Health |
SELL
Payment of exercise price or tax liability
|
Direct | 9,294 Reduced 6.11% |
$756,996
$81.45 p/Share
|
Feb 01
2018 |
|
LLY
|
Jeffrey N Simmons
SVP&Pres. Elanco Animal Health |
BUY
Exercise of conversion of derivative security
|
Direct | 21,326 Added 12.3% |
-
|
Feb 01
2018 |
|
AAPL
|
James A Bell
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 23.49% |
-
|
Feb 01
2018 |
|
AAPL
|
Albert Gore Jr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 16.59% |
-
|
Feb 01
2018 |
|
AAPL
|
Robert A Iger
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 3.62% |
-
|
Feb 01
2018 |
|
AAPL
|
Andrea Jung
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 7.99% |
-
|
Feb 01
2018 |
|
AAPL
|
Arthur D Levinson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 0.16% |
-
|
Feb 01
2018 |
|
AAPL
|
Ronald D Sugar
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 7.74% |
-
|
Feb 01
2018 |
|
AAPL
|
Susan Wagner
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,825 Added 15.36% |
-
|
Feb 01
2018 |
|
EVR
|
Roger C Altman
Founder and Senior Chairman |
BUY
Conversion of derivative security
|
Indirect | 75,000 Added 37.5% |
-
|
Feb 01
2018 |
|
EVR
|
Roger C Altman
Founder and Senior Chairman |
BUY
Conversion of derivative security
|
Direct | 100,000 Added 26.4% |
-
|
Feb 01
2018 |
|
EVR
|
Roger C Altman
Founder and Senior Chairman |
SELL
Open market or private sale
|
Direct | 21,888 Reduced 7.85% |
$2,234,546
$102.09 p/Share
|
Feb 01
2018 |
|
EVR
|
Roger C Altman
Founder and Senior Chairman |
SELL
Open market or private sale
|
Indirect | 26,125 Reduced 10.66% |
$2,668,146
$102.13 p/Share
|
Feb 01
2018 |
|
EVR
|
Ralph Schlosstein
Co-CEO/Co-Chairman |
BUY
Conversion of derivative security
|
Direct | 200,000 Added 38.65% |
-
|
Feb 01
2018 |
|
EVR
|
Ralph Schlosstein
Co-CEO/Co-Chairman |
BUY
Conversion of derivative security
|
Indirect | 100,000 Added 50.0% |
-
|
Feb 01
2018 |
|
EVR
|
Ralph Schlosstein
Co-CEO/Co-Chairman |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 25.0% |
$2,541,250
$101.65 p/Share
|
Feb 01
2018 |
|
SQ
|
Jacqueline D Reses
Capital Lead |
SELL
Payment of exercise price or tax liability
|
Direct | 12,005 Reduced 1.94% |
$533,622
$44.45 p/Share
|
Feb 01
2018 |
|
COF
|
Robert M. Alexander
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,342 Added 11.37% |
-
|
Feb 01
2018 |
|
COF
|
Jory A Berson |
BUY
Grant, award, or other acquisition
|
Direct | 11,140 Added 11.93% |
-
|
Feb 01
2018 |
|
COF
|
Richard Scott Blackley
Senior Advisor |
BUY
Grant, award, or other acquisition
|
Direct | 11,167 Added 17.56% |
-
|
Feb 01
2018 |
|
COF
|
Kevin S. Borgmann
Senior Advisor to the CEO |
BUY
Grant, award, or other acquisition
|
Direct | 13,146 Added 15.66% |
-
|
Feb 01
2018 |
|
COF
|
Noelle K Eder
Chief Card Cust. Exp. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,493 Added 16.09% |
-
|
Feb 01
2018 |
|
COF
|
Richard D Fairbank
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,043 Reduced 0.04% |
$109,223
$104.72 p/Share
|
Feb 01
2018 |
|
COF
|
Richard D Fairbank
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 667 Added 0.02% |
$69,848
$104.72 p/Share
|
Feb 01
2018 |
|
COF
|
John G Finneran Jr |
BUY
Grant, award, or other acquisition
|
Direct | 12,534 Added 10.31% |
-
|
Feb 01
2018 |
|
COF
|
Timothy P Golden
Controller |
BUY
Grant, award, or other acquisition
|
Direct | 2,865 Added 12.34% |
-
|
Feb 01
2018 |
|
COF
|
La Prade,Iii Frank G.
Chief Enterprise Srvcs Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,071 Added 16.63% |
-
|
Feb 01
2018 |
|
COF
|
Christopher T Newkirk
Pres,Small Bus, Intl & Walmart |
BUY
Grant, award, or other acquisition
|
Direct | 7,162 Added 17.6% |
-
|
Feb 01
2018 |
|
COF
|
Yajnik Sanjiv
President, Financial Services |
BUY
Grant, award, or other acquisition
|
Direct | 13,047 Added 13.37% |
-
|
Feb 01
2018 |
|
COF
|
Kleber Santos
Pres., Retail & Direct Banking |
BUY
Grant, award, or other acquisition
|
Direct | 6,827 Added 21.93% |
-
|
Feb 01
2018 |
|
COF
|
Michael Slocum
President, Commercial Banking |
BUY
Grant, award, or other acquisition
|
Direct | 11,044 Added 16.32% |
-
|
Feb 01
2018 |
|
COF
|
Michael J Wassmer
President, Card |
BUY
Grant, award, or other acquisition
|
Direct | 10,743 Added 10.6% |
-
|
Feb 01
2018 |
|
COF
|
Matthew W Cooper
General Counsel & Corp Secy |
BUY
Grant, award, or other acquisition
|
Direct | 8,443 Added 22.92% |
-
|
Feb 01
2018 |
|
ADI
|
Vincent Roche
Chair & CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 31.61% |
$912,500
$91.25 p/Share
|
Feb 01
2018 |
|
ADI
|
Vincent Roche
Chair & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 24.02% |
$459,500
$45.95 p/Share
|
Feb 01
2018 |
|
PRSO
|
Daniel Lee Lewis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 50.0% |
-
|
Feb 01
2018 |
|
PRSO
|
Daniel Joseph O'Neil
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 50.0% |
-
|
Feb 01
2018 |